Home › Research › How common it is
Midlife serum cholesterol and increased risk of Alzheimer's and vascular dementia three decades later
Solomon A, Kivipelto M, Wolozin B, Zhou J, Whitmer RA.. Dementia and geriatric cognitive disorders, 2009-08-04
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Aims To investigate midlife cholesterol in relation to Alzheimer's disease (AD) and vascular dementia (VaD) in a large multiethnic cohort of women and men. Methods The Kaiser Permanente Northern California Medical Group (healthcare delivery organization) formed the database for this study. The 9,844 participants underwent detailed health evaluations during 1964-1973 at ages 40-45 years; they were still members of the health plan in 1994. AD and VaD were ascertained by medical records between 1 January 1994 and 1 June 2007. Cox proportional hazards models - adjusted for age, education, race/ethnic group, sex, midlife diabetes, hypertension, BMI and late-life stroke - were conducted. Results In total, 469 participants had AD and 127 had VaD. With desirable cholesterol levels ( or=240 mg/dl), respectively. HR and 95% CI for VaD were 1.50 (1.01-2.23) for borderline and 1.26 (0.82-1.96) for high cholesterol. Further analyses for AD (cholesterol quartiles, 1st quartile reference) indicated that cholesterol levels >220 mg/dl were a significant risk factor: HR were 1.31 (1.01-1.71; 3rd quartile, 221-248 mg/dl) and 1.58 (1.22-2.06; 4th quartile, 249-500 mg/dl). Conclusion Midlife serum total cholesterol was associated with an increased risk of AD and VaD. Even moderately elevated cholesterol increased dementia risk. Dementia risk factors need to be addressed as early as midlife, before underlying disease(s) or symptoms appear.
What this study adds
Evidence grade: Moderate
The record lists 9,844 participants. For vascular dementia, borderline cholesterol was linked to higher risk (HR 1.50), but the high-cholesterol estimate was not statistically clear (HR 1.26, 95% CI 0.82–1.96). This is an observational association, and the authors' call to address risk factors from midlife is their conclusion, not something the study tested.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Solomon, A., Kivipelto, M., Wolozin, B., Zhou, J., & Whitmer, R. A. (2009). Midlife serum cholesterol and increased risk of Alzheimer's and vascular dementia three decades later. Dementia and geriatric cognitive disorders. https://doi.org/10.1159/000231980
Vancouver
Solomon A, Kivipelto M, Wolozin B, Zhou J, Whitmer RA. Midlife serum cholesterol and increased risk of Alzheimer's and vascular dementia three decades later. Dementia and geriatric cognitive disorders. 2009. doi:10.1159/000231980. PMID: 19648749.
BibTeX
@article{solomon2009-19648749,
author = {Solomon, A. and Kivipelto, M. and Wolozin, B. and Zhou, J. and Whitmer, R. A.},
title = {{Midlife serum cholesterol and increased risk of Alzheimer's and vascular dementia three decades later}},
journal = {Dementia and geriatric cognitive disorders},
year = {2009},
doi = {10.1159/000231980},
pmid = {19648749},
url = {https://doi.org/10.1159/000231980}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Results In total, 469 participants had AD and 127 had VaD.
- Further analyses for AD (cholesterol quartiles, 1st quartile reference) indicated that cholesterol levels >220 mg/dl were a significant risk factor: HR were 1.31 (1.01-1.71; 3rd quartile, 221-248 mg/dl) and 1.58 (1.22-2.06; 4th quartile, 249-500 mg/dl).
- Conclusion Midlife serum total cholesterol was associated with an increased risk of AD and VaD.
Why it matters
In 9,844 Kaiser Permanente members whose cholesterol was measured at ages 40–45 in 1964–1973, those in the top two quartiles of total cholesterol (221–248 and 249–500 mg/dl) were more likely to have Alzheimer's disease recorded in 1994–2007 than those in the lowest quartile (hazard ratios 1.31 and 1.58, after adjusting for age, sex, education, race/ethnicity, diabetes, hypertension, BMI and late-life stroke). For vascular dementia, borderline cholesterol was linked to higher risk (HR 1.50), but the high-cholesterol estimate was not statistically clear (HR 1.26, 95% CI 0.82–1.96). This is an observational association, and the authors' call to address risk factors from midlife is their conclusion, not something the study tested.
New to this subject? Start with our plain-English guide: Alzheimer's in numbers →
Study details
- Participants9,844
- Evidence strengthModerate
How this study scored 57/100
Published in a peer-reviewed journal. Scored zero for study design, effect reported and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Dementia and geriatric cognitive disorders) |
| Journal's citation record | 1 / 4 | Dementia and Geriatric Cognitive Disorders: journal h-index 149 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2009 — within 20 year(s) of the newest study here |
| Sample size | 3 / 4 | 9,844 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 6 / 7 | Cited 560 times (OpenAlex, 2026-10-10) |
| Citations per year | 4 / 5 | 29.5 citations a year over 19 year(s) since 2009 |
| Impact for its field and year | 4 / 6 | Cited 17.8× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 4 / 6 | Cited by 38 other studies in this library |
| Still being cited | 3 / 4 | Cited 83 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Rachel A. Whitmer: h-index 63 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | Karolinska Institutet: institution h-index 1,477 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 4 institution(s) in 3 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 19648749) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 57 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1159/000231980
- PubMed: 19648749
- Original source →
- Free full text: Dementia and Geriatric Cognitive Disorders →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
38 studies in the alzhub library list this one in their references. Showing the 8 highest-scoring.
Related studies in How common it is from nearby years
Also tagged “biobank”
1,084 studies in the library carry the topic tag “biobank”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,084 tagged studies.